AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH). It has been studied for its potential role in supporting lipid metabolism without exerting the broader systemic growth-promoting effects associated with full-length growth hormone.

Preclinical research suggests that AOD-9604 may influence pathways involved in lipolysis (the breakdown of stored fat) and may inhibit lipogenesis (the formation of new fat) in experimental models. These mechanisms are believed to contribute to its observed effects in laboratory studies examining metabolic signaling, body composition pathways, and energy regulation. Unlike intact growth hormone, AOD-9604 has been investigated specifically for targeted metabolic pathway interaction rather than generalized anabolic activity.

Beyond its metabolic focus, AOD-9604 has also been explored in preclinical settings for its potential influence on cartilage and connective tissue–related signaling pathways. Ongoing research continues to evaluate its role in metabolic regulation, tissue-associated signaling, and adaptive physiological processes.